Kathryn Myhill
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.
Journal: Hereditary cancer in clinical practice
Published: April 01, 2026
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.
Journal: The New England journal of medicine
Published: April 11, 2025
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
Journal: BJU international
Published: June 05, 2024
Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants.
Journal: BJUI compass
Published: January 07, 2022
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Journal: The Lancet. Oncology
Published: July 02, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.
Journal: BJU international
Published: December 17, 2020
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
Journal: BJU international
Published: May 27, 2018
Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London.
Journal: Familial cancer
Published: October 22, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026